Genetic, biochemical, and structural characterization of a novel KLUS subgroup of CTX-M-type extended-spectrum β-lactamases reveals an evolutionarily distinct lineage with unique functional properties
Abstract
Extended-spectrum β-lactamases (ESBLs), particularly the CTX-M family, have progressively undermined the clinical utility of β-lactam antibiotics. Herein, we identified and characterized a novel CTX-M subgroup designated KLUS, and investigated its taxonomic position and functional properties. Phylogenetic analysis combined with genetic distance calculations supported KLUS as a distinct lineage, with inter-subgroup distances significantly exceeding intra-subgroup distances and distinct clustering (bootstrap support >95%), consistent with the previously established family-wide CTX-M classification. Recombinant plasmids harboring each of the four blaKLUS alleles were constructed in E. coli BL21 (DE3), with optimal expression achieved using 1.0 mM IPTG at 30 °C for 5 h. Minimum inhibitory concentration (MIC) determinations revealed that KLUS-1 through KLUS-3 conferred high-level resistance to ampicillin and ceftriaxone, moderate resistance to cefotaxime, and minimal resistance to ceftazidime (MIC < 0.125 μg/mL). KLUS-4 exhibited enhanced ceftazidime resistance (MIC = 8 μg/mL) and a reduced inhibitor response at the phenotypic level (a 16-fold reduction of the cefotaxime MIC with clavulanic acid, in contrast to KLUS-1, where clavulanic acid reduced the MIC to <0.015 μg/mL). β-lactamase inhibitors reduced cefotaxime MICs far exceeding 16-fold in KLUS-1 through KLUS-3, consistent with ESBL phenotypes. Steady-state kinetic analyses demonstrated subtype-dependent catalytic efficiencies that were highest for ampicillin and penicillin G in KLUS-2/3/4 and for ceftriaxone in KLUS-1, broadly consistent with MIC results. The substantially lower catalytic efficiency for ceftazidime may explain its reduced resistance phenotype. Structural modeling revealed that KLUS enzymes comprise 11 α-helices and 5 β-sheets, with a conserved catalytic cavity and SDN loop. Twenty-three unique amino acid substitutions distinguish KLUS from CTX-M-2. V77I (pre-protein positions 106) is located proximal to the Ω-loop region, and any functional contribution of this conservative substitution remains speculative. These findings expand the known diversity of CTX-M β-lactamases; the clinical significance of KLUS requires further investigation in clinical isolates.
Related
- Functional and biochemical characterization of Alyftrek® components reveals high-potency rescue of F508del-CFTR
- Potential Protective Role of Naringin against Energy Drinks-Induced Hippocampal Neurotoxicity: Structural, Functional and Biochemical Study
- Polysaccharides from Algerian Opuntia ficus-indica Cladodes: Structural Characterization, Functional properties, and Cytotoxic Effects on U87 Human Glioblastoma Cells
- Morphological and biochemical characterization of Capsicum annuum landrace Durgada for potential geographical indication status in Andhra Pradesh, India
- Structural and biochemical analysis of the IBV nsp15 endoribonuclease reveals the necessity of peripheral site residues for activity
BibTeX
@article{huang2026genetic,
title = {{Genetic, biochemical, and structural characterization of a novel KLUS subgroup of CTX-M-type extended-spectrum β-lactamases reveals an evolutionarily distinct lineage with unique functional properties}},
author = {Zhenzhou Huang and Jun Li and Xiao Liu and Lingyi Zeng and Zhibei Zheng and Hua Yu and Duochun Wang and Keyi Yu and Junfang Chen},
journal = {Frontiers in Microbiology},
year = {2026},
month = oct,
doi = {10.3389/fmicb.2026.1997337},
url = {https://www.frontiersin.org/articles/10.3389/fmicb.2026.1997337},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Genetic, biochemical, and structural characterization of a novel KLUS subgroup of CTX-M-type extended-spectrum β-lactamases reveals an evolutionarily distinct lineage with unique functional properties
AU - Zhenzhou Huang
AU - Jun Li
AU - Xiao Liu
AU - Lingyi Zeng
AU - Zhibei Zheng
AU - Hua Yu
AU - Duochun Wang
AU - Keyi Yu
AU - Junfang Chen
PY - 2026
DA - 2026/10/30
JO - Frontiers in Microbiology
DO - 10.3389/fmicb.2026.1997337
UR - https://www.frontiersin.org/articles/10.3389/fmicb.2026.1997337
AB - Extended-spectrum β-lactamases (ESBLs), particularly the CTX-M family, have progressively undermined the clinical utility of β-lactam antibiotics. Herein, we identified and characterized a novel CTX-M subgroup designated KLUS, and investigated its taxonomic position and functional properties. Phylogenetic analysis combined with genetic distance calculations supported KLUS as a distinct lineage, with inter-subgroup distances significantly exceeding intra-subgroup distances and distinct clustering (bootstrap support >95%), consistent with the previously established family-wide CTX-M classification. Recombinant plasmids harboring each of the four blaKLUS alleles were constructed in E. coli BL21 (DE3), with optimal expression achieved using 1.0 mM IPTG at 30 °C for 5 h. Minimum inhibitory concentration (MIC) determinations revealed that KLUS-1 through KLUS-3 conferred high-level resistance to ampicillin and ceftriaxone, moderate resistance to cefotaxime, and minimal resistance to ceftazidime (MIC < 0.125 μg/mL). KLUS-4 exhibited enhanced ceftazidime resistance (MIC = 8 μg/mL) and a reduced inhibitor response at the phenotypic level (a 16-fold reduction of the cefotaxime MIC with clavulanic acid, in contrast to KLUS-1, where clavulanic acid reduced the MIC to <0.015 μg/mL). β-lactamase inhibitors reduced cefotaxime MICs far exceeding 16-fold in KLUS-1 through KLUS-3, consistent with ESBL phenotypes. Steady-state kinetic analyses demonstrated subtype-dependent catalytic efficiencies that were highest for ampicillin and penicillin G in KLUS-2/3/4 and for ceftriaxone in KLUS-1, broadly consistent with MIC results. The substantially lower catalytic efficiency for ceftazidime may explain its reduced resistance phenotype. Structural modeling revealed that KLUS enzymes comprise 11 α-helices and 5 β-sheets, with a conserved catalytic cavity and SDN loop. Twenty-three unique amino acid substitutions distinguish KLUS from CTX-M-2. V77I (pre-protein positions 106) is located proximal to the Ω-loop region, and any functional contribution of this conservative substitution remains speculative. These findings expand the known diversity of CTX-M β-lactamases; the clinical significance of KLUS requires further investigation in clinical isolates.
SN - 1664-302X
ER -